Product Manual

QuickTiter™ Hepatitis B "e" Antigen (HBeAg)ELISA Kit
Catalog Numbers
VPK-5003

96 assays

VPK-5003-5

5 x 96 assays

FOR RESEARCH USE ONLY
Not for use in diagnostic procedures

Introduction
Hepatitis B is an infection of the liver caused by the hepatitis B virus. HBV is transmitted by exposure
to infectious blood or body fluids (e.g. saliva, semen, urine); forms of transmission include unprotected
sexual activity, blood transfusion, mother-to-infant transmission, or consuming contaminatedfood/water. The acute illness causes liver inflammation, vomiting and jaundice, while chronic HBV
infection often leads to liver cirrhosis and cancer.
Roughly one third of the world’s population have been infected with hepatitis B virus. 5-10% of adults
and 90% of babies who have been infected will have the virus for the rest of their lives. The infection
is preventable by vaccination.
Diagnosis of chronic Hepatitis B Virus (HBV) infection has long been based on HBV serology andmeasurement of hepatocytic enzymes. With the development of therapies for chronic HBV infection,
including interferon and lamivudine, quantitative detection of HBV (viral antigens and patientantibodies) has been used increasingly as the most important marker for monitoring HBV replication
activity, disease progression, and assessing antiviral treatment. Specifically, Hepatitis B "e" antigen(HBeAg) is an important diagnostic marker, generally detectable in patients with acute infection;
positive testing indicates high HBV replication in the liver, elevated blood HBV titers and greater
infectivity to others. Several assays for the quantitative measurement of HBV DNA have beendeveloped, such as PCR-based nucleic acid amplification assays. However, these methods tend to becumbersome and expensive.
Cell Biolabs’ QuickTiter™ HBeAg ELISA Kit is an enzyme immunoassay developed for detection
and quantitation of the Hepatitis B "e" Antigen. The kit has detection sensitivity limit of ~150 pg/mL
HBeAg. Each kit provides sufficient reagents to perform up to 96 assays including standard curve andHBeAg samples.

Assay Principle
An anti-HBeAg monoclonal coating antibody is adsorbed onto a microtiter plate. Hepatitis B "e"antigen present in the sample or standard binds to the antibodies adsorbed on the plate; aFITC-conjugated mouse anti-HBeAg antibody is added and binds to the antigen captured by the firstantibody. Following incubation and wash steps, an HRP-conjugated mouse anti-FITC antibody isadded and binds to the FITC conjugated anti-HBeAg. Unbound HRP-conjugated mouse anti-FITC
antibody is removed during a wash step, and substrate solution reactive with HRP is added to thewells. A colored product is formed in proportion to the amount of HBeAg present in the sample. Thereaction is terminated by addition of acid and absorbance is measured at 450 nm. A standard curve isprepared from recombinant HBeAg and sample concentration is then determined.

Related Products
1. VPK-150: QuickTiter™ HBcAg ELISA Kit
2. VPK-151: QuickTiter™ HCcAg ELISA Kit
3. VPK-5004: QuickTiter™ HBsAg ELISA Kit
4. VPK-108-H: QuickTiter™ Lentivirus Quantitation Kit (HIV-1 p24 ELISA)
2

5. VPK-107: QuickTiter™ Lentivirus Titer Kit (Lentivirus-Associated HIV p24)
6. VPK-112: QuickTiter™ Lentivirus Quantitation Kit
7. LTV-200: ViraDuctin™ Lentivirus Transduction Kit

Kit Components
Box 1 (shipped at room temperature)
1. Anti-HBeAg Antibody Coated Plate (Part No. 50031B): One strip well 96-well plate.
2. FITC-Conjugated Anti-HBeAg Monoclonal Antibody (Part No. 50032C): One 20 µL ambervial.
3. HRP-Conjugated Anti-FITC Monoclonal Antibody (Part No. 310811): One 20 µL vial.
4. Assay Diluent (Part No. 310804): One 50 mL bottle.
5. Triton X-100 Solution (Part No. 310805): One 15 mL bottle containing 5% Triton X-100 inTBS.
6. 10X Wash Buffer (Part No. 310806): One 100 mL bottle.
7. Substrate Solution (Part No. 310807): One 12 mL amber bottle.
8. Stop Solution (Part. No. 310808): One 12 mL bottle.
Box 2 (shipped on blue ice packs)
1. Recombinant HBeAg Standard (Part No. 50033C): One 100 µL vial of 1 µg/mL recombinant
HBeAg in PBS containing BSA.

Materials Not Supplied
1. HBV Sample: purified virus or unpurified viral supernatant
2. Cell Culture Centrifuge
3.
4.
5.
6.
7.

0.45 µm filter
10 µL to 1000 µL adjustable single channel micropipettes with disposable tips
50 µL to 300 µL adjustable multichannel micropipette with disposable tips
Multichannel micropipette reservoir
Microplate reader capable of reading at 450 nm (620 nm as optional reference wave length)

StorageUpon receiving, aliquot and store recombinant HBeAg Standard at -20ºC and avoid freeze/thaw. Store
all other components at 4ºC.

Safety Considerations
Remember that your samples contain infectious viruses before inactivation; you must follow therecommended NIH guidelines for all materials containing infectious organisms.
3

Preparation of Reagents•1X Wash Buffer: Dilute the 10X Wash Buffer to 1X with deionized water. Stir to homogeneity.

•FITC-Conjugated Anti-HBeAg Monoclonal Antibody and HRP-Conjugated Anti-FITCMonoclonal Antibody: Immediately before use dilute the FITC-conjugated antibody 1:1000 andHRP-conjugated antibody 1:1000 with Assay Diluent. Do not store diluted solutions.

Preparation of Standard Curve
1. Prepare a dilution series of Recombinant HBeAg Standard in the concentration range of 10 ng/mL– 0.156 ng/mL by diluting the stock solution in Assay Diluent (Table 1).
StandardTubes
12345678HBeAg
Standard (µL)
10500 of Tube #1500 of Tube #2500 of Tube #3500 of Tube #4500 of Tube #5500 of Tube #60Assay Diluent
(µL)
990
500
500
500
500
500
500
500

HBeAg
(ng/mL)
105
2.5
1.25
0.625
0.313
0.156
0

Table 1. Preparation of HBeAg Standard
2. Transfer 225µL of each dilution to a microcentrifuge tube containing 25 µL of Triton X-100
Solution. Perform the assay as described in Assay Instructions.

HBV Sample Dilution and Inactivation
1. (Optional) Dilute HBeAg sample in culture medium.
control.

Include culture medium as a negative

2. Transfer 225 µL of each sample to a microcentrifuge tube containing 25 µL of Triton X-100Solution, Vortex well.
3. Incubate 30 minutes at 37ºC.
Note: For samples containing antibodies, inactivate by incubating at 56ºC for 30 min.

Assay Protocol
1. Prepare and mix all reagents thoroughly before use.
2. Each HBeAg sample, HBeAg standard, blank, and control medium should be assayed in duplicate.
43. Add 100 µL of inactivated sample or HBeAg standard to Anti-HBeAg Antibody Coated Plate.
4. Cover with a plate cover and incubate at 37ºC for 2 hours.
5. Remove plate cover and empty wells. Wash microwell strips 5 times with 250 µL 1X Wash Buffer
per well with thorough aspiration between each wash. After the last wash, empty wells and tap
microwell strips on absorbent pad or paper towel to remove excess 1X Wash Buffer.
6. Add 100 µL of the diluted FITC-Conjugated Anti-HBeAg Monoclonal Antibody to each well.
7. Cover with a plate cover and incubate at room temperature for 1 hour on an orbital shaker.
8. Remove plate cover and empty wells. Wash the strip wells 5 times according to step 5 above.
9. Add 100 µL of the diluted HRP-Conjugated Anti-FITC Monoclonal Antibody to all wells.
10. Cover with a plate cover and incubate at room temperature for 1 hour on an orbital shaker.
11. Remove plate cover and empty wells. Wash microwell strips 5 times according to step 5 above.
Proceed immediately to the next step.
12. Warm Substrate Solution to room temperature. Add 100 L of Substrate Solution to each well,including the blank wells. Incubate at room temperature on an orbital shaker. Actual incubation
time may vary from 5-20 minutes.
Note: Watch plate carefully; if color changes rapidly, the reaction may need to be stopped sooner
to prevent saturation.
13. Stop the enzyme reaction by adding 100 µL of Stop Solution into each well, including the blankwells. Results should be read immediately (color will fade over time).
14. Read absorbance of each microwell on a spectrophotometer using 450 nm as the primary wave
length.

Example of Results
The following figures demonstrate typical HBeAg ELISA results. One should use the data below forreference only. This data should not be used to interpret actual results.

5

Figure 1: HBeAg ELISA Standard Curve

References
1. Bottcher, B., S. A. Wynne, and R. A. Crowther (1997) Nature 386:88-91. 4
2. Bredehorst, R., H. von Wulffen, and C. Granato (1985) J. Clin. Microbiol. 21:593-598. 5
3. Kimura, T., A. Rokuhara, Y. Sakamoto, S. Yagi, E. Tanaka, K. Kiyosawa, and N. Maki (2002)
J. Clin. Microbiol. 40:439-445. 15
4. Usuda, S., H. Okamoto, F. Tsuda, T. Tanaka, Y. Miyakawa, and M. Mayumi (1998) J. Virol.
Methods 72:95-103. 30

Recent Product Citations
1. Alheany, A.R. & Abdullah, S.F. (2022). Status of HBeAg in association with other baseline
tests in Iraqi patients with CHB. Research J. Pharm. and Tech. 15(8):3475-3478. doi:
10.52711/0974-360X.2022.00582.
6

2. Du, N. et al. (2022). CircRNA circBACH1 facilitates hepatitis B virus replication andhepatoma development by regulating the miR-200a-3p/MAP3K2 axis. Histol Histopathol. doi:
10.14670/HH-18-452.
3. Zhao, Y. et al. (2019). MiR-3613-3p impairs IFN-induced immune response by targeting
CMPK1 in chronic hepatitis B. Infect Genet Evol. 103919. doi: 10.1016/j.meegid.2019.103919.
4. Domfeh, S.A. et al. (2021). Cryptolepine and Nibima inhibit hepatitis B virus replication. Sci
Afr. doi: 10.1016/j.sciaf.2021.e00942.

Warranty
These products are warranted to perform as described in their labeling and in Cell Biolabs literature when used inaccordance with their instructions. THERE ARE NO WARRANTIES THAT EXTEND BEYOND THIS EXPRESSEDWARRANTY AND CELL BIOLABS DISCLAIMS ANY IMPLIED WARRANTY OF MERCHANTABILITY ORWARRANTY OF FITNESS FOR PARTICULAR PURPOSE. CELL BIOLABS’s sole obligation and purchaser’s
exclusive remedy for breach of this warranty shall be, at the option of CELL BIOLABS, to repair or replace the products.
In no event shall CELL BIOLABS be liable for any proximate, incidental or consequential damages in connection with theproducts.

Contact Information
Cell Biolabs, Inc.
5628 Copley DriveSan Diego, CA 92111
Worldwide: +1 858-271-6500
USA Toll-Free: 1-888-CBL-0505
E-mail: tech@cellbiolabs.com
www.cellbiolabs.com©2015-2024: Cell Biolabs, Inc. - All rights reserved. No part of these works may be reproduced in any form without
permissions in writing.

7